1995
DOI: 10.1080/10720169508400065
|View full text |Cite
|
Sign up to set email alerts
|

An olfactory perversion (osmophilia) successfully treated with depo-provera and then psychotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1996
1996
2019
2019

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Most clinicians, however, advocate that antiandrogen therapy be used in conjunction with some form of psychotherapy (Langevin et al, 1979;Lothstein, 1995;McConaghy et al, 1988;Moffaert, 1976;Money, 1981Money, , 1987Money & Bennett, 1981;Money et al, 1975). While antiandrogen treatment provides a respite from sexual drive, only psychotherapy (in its broadest sense) can help integrate one's sexual needs and intimacy strivings effectively.…”
Section: Issues In Antiandrogen Treatmentmentioning
confidence: 95%
See 1 more Smart Citation
“…Most clinicians, however, advocate that antiandrogen therapy be used in conjunction with some form of psychotherapy (Langevin et al, 1979;Lothstein, 1995;McConaghy et al, 1988;Moffaert, 1976;Money, 1981Money, , 1987Money & Bennett, 1981;Money et al, 1975). While antiandrogen treatment provides a respite from sexual drive, only psychotherapy (in its broadest sense) can help integrate one's sexual needs and intimacy strivings effectively.…”
Section: Issues In Antiandrogen Treatmentmentioning
confidence: 95%
“…While antiandrogen treatment provides a respite from sexual drive, only psychotherapy (in its broadest sense) can help integrate one's sexual needs and intimacy strivings effectively. I (Lothstein, 1995) have written: "It would appear then that two processes may be involved in perverse symptom formation. The first process focuses on the maintenance of the perversion by the individual's specific neurobiology.…”
Section: Issues In Antiandrogen Treatmentmentioning
confidence: 98%